Global Amifostine Market by Manufacturers, Regions, Type and Application, Forecast to 2023
- GLO2648765
- 128 Pages
- July 2018
- Pharmaceuticals
Scope of the Report:
This report focuses on the Amifostine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Amifostine is a pro-drug which is activated to the free thiol metabolite at the tissue site. The thiol metabolite is responsible for most of the cytoprotective and radioprotective properties of amifostine. It is readily taken up by cells where it binds to and detoxifies reactive metabolites of platinum and alkylating agents as well as scavenges free radicals. Other possible effects include inhibition of apoptosis, alteration of gene expression and modification of enzyme activity. Healthy cells are preferentially protected because amifostine and metabolites are present in healthy cells at 100-fold greater concentrations than in tumour cells.
Consumption of amifostine mainly concentrates in North America. In 2016, the region consumed 780 K Unit, holding about 52% market share globally. The follower is Asia-Pacific, with about 41% consumption share.
The market is relatively concentrated and there are just a few suppliers in the market, such as Clinigen Group, Sun Pharmaceutical, Merro Pharmaceutical and so on. Clinigen Group acquired the business from AstraZeneca in the year of 2014 and signed an agreement with Cumberland in the year of 2016. Under the agreement, Cumberland acquired the exclusive rights to commercialize Ethyol in the United States. Merro Pharmaceutical own the largest sales share in China.
Amifostine shows good effect in reducing harmful effects of cisplatin chemotherapy on kidneys in women treated for advanced ovarian cancer as well as relieving dry mouth problems (xerostomia) with head and neck cancer patients undergoing radiation treatment. It is estimated that the amifostine market will keep upward tendency and to be worthy of 49.99 million USD in 2023 globally.
The worldwide market for Amifostine is expected to grow at a CAGR of roughly 2.1% over the next five years, will reach 54 million US$ in 2023, from 48 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
400mg/Dose
500mg/Dose
Market Segment by Applications, can be divided into
Head and Neck Cancer Adjuvant Therapy
Others
There are 15 Chapters to deeply display the global Amifostine market.
Chapter 1, to describe Amifostine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Amifostine, with sales, revenue, and price of Amifostine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Amifostine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Amifostine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Amifostine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 Market Overview
1.1 Amifostine Introduction
1.2 Market Analysis by Type
1.2.1 400mg/Dose
1.2.2 500mg/Dose
1.3 Market Analysis by Applications
1.3.1 Head and Neck Cancer Adjuvant Therapy
1.3.2 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Clinigen Group
2.1.1 Business Overview
2.1.2 Amifostine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sun Pharmaceutical
2.2.1 Business Overview
2.2.2 Amifostine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Taj Pharmaceuticals
2.3.1 Business Overview
2.3.2 Amifostine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merro Pharmaceutical
2.4.1 Business Overview
2.4.2 Amifostine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Luye Pharma
2.5.1 Business Overview
2.5.2 Amifostine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mingren Pharma
2.6.1 Business Overview
2.6.2 Amifostine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Amifostine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Amifostine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Amifostine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Amifostine Manufacturer Market Share in 2017
3.3.2 Top 6 Amifostine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Amifostine Market Analysis by Regions
4.1 Global Amifostine Sales, Revenue and Market Share by Regions
4.1.1 Global Amifostine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Amifostine Revenue and Market Share by Regions (2013-2018)
4.2 North America Amifostine Sales and Growth Rate (2013-2018)
4.3 Europe Amifostine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Amifostine Sales and Growth Rate (2013-2018)
4.5 South America Amifostine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Amifostine Sales and Growth Rate (2013-2018)
5 North America Amifostine by Countries
5.1 North America Amifostine Sales, Revenue and Market Share by Countries
5.1.1 North America Amifostine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Amifostine Revenue and Market Share by Countries (2013-2018)
5.2 United States Amifostine Sales and Growth Rate (2013-2018)
5.3 Canada Amifostine Sales and Growth Rate (2013-2018)
5.4 Mexico Amifostine Sales and Growth Rate (2013-2018)
6 Europe Amifostine by Countries
6.1 Europe Amifostine Sales, Revenue and Market Share by Countries
6.1.1 Europe Amifostine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Amifostine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Amifostine Sales and Growth Rate (2013-2018)
6.3 UK Amifostine Sales and Growth Rate (2013-2018)
6.4 France Amifostine Sales and Growth Rate (2013-2018)
6.5 Russia Amifostine Sales and Growth Rate (2013-2018)
6.6 Italy Amifostine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Amifostine by Countries
7.1 Asia-Pacific Amifostine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Amifostine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Amifostine Revenue and Market Share by Countries (2013-2018)
7.2 China Amifostine Sales and Growth Rate (2013-2018)
7.3 Japan Amifostine Sales and Growth Rate (2013-2018)
7.4 Korea Amifostine Sales and Growth Rate (2013-2018)
7.5 India Amifostine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Amifostine Sales and Growth Rate (2013-2018)
8 South America Amifostine by Countries
8.1 South America Amifostine Sales, Revenue and Market Share by Countries
8.1.1 South America Amifostine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Amifostine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Amifostine Sales and Growth Rate (2013-2018)
8.3 Argentina Amifostine Sales and Growth Rate (2013-2018)
8.4 Colombia Amifostine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Amifostine by Countries
9.1 Middle East and Africa Amifostine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Amifostine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Amifostine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Amifostine Sales and Growth Rate (2013-2018)
9.3 UAE Amifostine Sales and Growth Rate (2013-2018)
9.4 Egypt Amifostine Sales and Growth Rate (2013-2018)
9.5 Nigeria Amifostine Sales and Growth Rate (2013-2018)
9.6 South Africa Amifostine Sales and Growth Rate (2013-2018)
10 Global Amifostine Market Segment by Type
10.1 Global Amifostine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Amifostine Sales and Market Share by Type (2013-2018)
10.1.2 Global Amifostine Revenue and Market Share by Type (2013-2018)
10.2 400mg/Dose Sales Growth and Price
10.2.1 Global 400mg/Dose Sales Growth (2013-2018)
10.2.2 Global 400mg/Dose Price (2013-2018)
10.3 500mg/Dose Sales Growth and Price
10.3.1 Global 500mg/Dose Sales Growth (2013-2018)
10.3.2 Global 500mg/Dose Price (2013-2018)
11 Global Amifostine Market Segment by Application
11.1 Global Amifostine Sales Market Share by Application (2013-2018)
11.2 Head and Neck Cancer Adjuvant Therapy Sales Growth (2013-2018)
11.3 Others Sales Growth (2013-2018)
12 Amifostine Market Forecast (2018-2023)
12.1 Global Amifostine Sales, Revenue and Growth Rate (2018-2023)
12.2 Amifostine Market Forecast by Regions (2018-2023)
12.2.1 North America Amifostine Market Forecast (2018-2023)
12.2.2 Europe Amifostine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Amifostine Market Forecast (2018-2023)
12.2.4 South America Amifostine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Amifostine Market Forecast (2018-2023)
12.3 Amifostine Market Forecast by Type (2018-2023)
12.3.1 Global Amifostine Sales Forecast by Type (2018-2023)
12.3.2 Global Amifostine Market Share Forecast by Type (2018-2023)
12.4 Amifostine Market Forecast by Application (2018-2023)
12.4.1 Global Amifostine Sales Forecast by Application (2018-2023)
12.4.2 Global Amifostine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Amifostine Picture
Table Product Specifications of Amifostine
Figure Global Sales Market Share of Amifostine by Types in 2017
Table Amifostine Types for Major Manufacturers
Figure 400mg/Dose Picture
Figure 500mg/Dose Picture
Figure Amifostine Sales Market Share by Applications in 2017
Figure Head and Neck Cancer Adjuvant Therapy Picture
Figure Others Picture
Figure United States Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure France Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure China Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure India Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Amifostine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Amifostine Revenue (Value) and Growth Rate (2013-2023)
Table Clinigen Group Basic Information, Manufacturing Base and Competitors
Table Clinigen Group Amifostine Type and Applications
Table Clinigen Group Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Amifostine Type and Applications
Table Sun Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Amifostine Type and Applications
Table Taj Pharmaceuticals Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Merro Pharmaceutical Amifostine Type and Applications
Table Merro Pharmaceutical Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Luye Pharma Basic Information, Manufacturing Base and Competitors
Table Luye Pharma Amifostine Type and Applications
Table Luye Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mingren Pharma Basic Information, Manufacturing Base and Competitors
Table Mingren Pharma Amifostine Type and Applications
Table Mingren Pharma Amifostine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Amifostine Sales by Manufacturer (2016-2017)
Figure Global Amifostine Sales Market Share by Manufacturer in 2016
Figure Global Amifostine Sales Market Share by Manufacturer in 2017
Table Global Amifostine Revenue by Manufacturer (2016-2017)
Figure Global Amifostine Revenue Market Share by Manufacturer in 2016
Figure Global Amifostine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Amifostine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Amifostine Manufacturer (Revenue) Market Share in 2017
Figure Global Amifostine Sales and Growth Rate (2013-2018)
Figure Global Amifostine Revenue and Growth Rate (2013-2018)
Table Global Amifostine Sales by Regions (2013-2018)
Table Global Amifostine Sales Market Share by Regions (2013-2018)
Table Global Amifostine Revenue by Regions (2013-2018)
Figure Global Amifostine Revenue Market Share by Regions in 2013
Figure Global Amifostine Revenue Market Share by Regions in 2017
Figure North America Amifostine Sales and Growth Rate (2013-2018)
Figure Europe Amifostine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Amifostine Sales and Growth Rate (2013-2018)
Figure South America Amifostine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Amifostine Sales and Growth Rate (2013-2018)
Figure North America Amifostine Revenue and Growth Rate (2013-2018)
Table North America Amifostine Sales by Countries (2013-2018)
Table North America Amifostine Sales Market Share by Countries (2013-2018)
Figure North America Amifostine Sales Market Share by Countries in 2013
Figure North America Amifostine Sales Market Share by Countries in 2017
Table North America Amifostine Revenue by Countries (2013-2018)
Table North America Amifostine Revenue Market Share by Countries (2013-2018)
Figure North America Amifostine Revenue Market Share by Countries in 2013
Figure North America Amifostine Revenue Market Share by Countries in 2017
Figure United States Amifostine Sales and Growth Rate (2013-2018)
Figure Canada Amifostine Sales and Growth Rate (2013-2018)
Figure Mexico Amifostine Sales and Growth Rate (2013-2018)
Figure Europe Amifostine Revenue and Growth Rate (2013-2018)
Table Europe Amifostine Sales by Countries (2013-2018)
Table Europe Amifostine Sales Market Share by Countries (2013-2018)
Table Europe Amifostine Revenue by Countries (2013-2018)
Figure Europe Amifostine Revenue Market Share by Countries in 2016
Figure Europe Amifostine Revenue Market Share by Countries in 2017
Figure Germany Amifostine Sales and Growth Rate (2013-2018)
Figure UK Amifostine Sales and Growth Rate (2013-2018)
Figure France Amifostine Sales and Growth Rate (2013-2018)
Figure Russia Amifostine Sales and Growth Rate (2013-2018)
Figure Italy Amifostine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Amifostine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Amifostine Sales by Countries (2013-2018)
Table Asia-Pacific Amifostine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Amifostine Sales Market Share by Countries 2017
Table Asia-Pacific Amifostine Revenue by Countries (2013-2018)
Figure Asia-Pacific Amifostine Revenue Market Share by Countries 2017
Figure China Amifostine Sales and Growth Rate (2013-2018)
Figure Japan Amifostine Sales and Growth Rate (2013-2018)
Figure Korea Amifostine Sales and Growth Rate (2013-2018)
Figure India Amifostine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Amifostine Sales and Growth Rate (2013-2018)
Figure South America Amifostine Revenue and Growth Rate (2013-2018)
Table South America Amifostine Sales by Countries (2013-2018)
Table South America Amifostine Sales Market Share by Countries (2013-2018)
Figure South America Amifostine Sales Market Share by Countries in 2017
Table South America Amifostine Revenue by Countries (2013-2018)
Table South America Amifostine Revenue Market Share by Countries (2013-2018)
Figure South America Amifostine Revenue Market Share by Countries in 2017
Figure Brazil Amifostine Sales and Growth Rate (2013-2018)
Figure Argentina Amifostine Sales and Growth Rate (2013-2018)
Figure Colombia Amifostine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Amifostine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Amifostine Sales by Countries (2013-2018)
Table Middle East and Africa Amifostine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Amifostine Sales Market Share by Countries in 2017
Table Middle East and Africa Amifostine Revenue by Countries (2013-2018)
Table Middle East and Africa Amifostine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Amifostine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Amifostine Sales and Growth Rate (2013-2018)
Figure UAE Amifostine Sales and Growth Rate (2013-2018)
Figure Egypt Amifostine Sales and Growth Rate (2013-2018)
Figure Nigeria Amifostine Sales and Growth Rate (2013-2018)
Figure South Africa Amifostine Sales and Growth Rate (2013-2018)
Table Global Amifostine Sales by Type (2013-2018)
Table Global Amifostine Sales Share by Type (2013-2018)
Table Global Amifostine Revenue by Type (2013-2018)
Table Global Amifostine Revenue Share by Type (2013-2018)
Figure Global 400mg/Dose Sales Growth (2013-2018)
Figure Global 400mg/Dose Price (2013-2018)
Figure Global 500mg/Dose Sales Growth (2013-2018)
Figure Global 500mg/Dose Price (2013-2018)
Table Global Amifostine Sales by Application (2013-2018)
Table Global Amifostine Sales Share by Application (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Amifostine Sales, Revenue and Growth Rate (2018-2023)
Table Global Amifostine Sales Forecast by Regions (2018-2023)
Table Global Amifostine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Amifostine Market Forecast (2018-2023)
Figure Europe Sales Amifostine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Amifostine Market Forecast (2018-2023)
Figure South America Sales Amifostine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Amifostine Market Forecast (2018-2023)
Table Global Amifostine Sales Forecast by Type (2018-2023)
Table Global Amifostine Market Share Forecast by Type (2018-2023)
Table Global Amifostine Sales Forecast by Application (2018-2023)
Table Global Amifostine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
